Summary
This prediction ended on 26.02.24 with a price of €28.69. The BUY prediction by Biggybaer for Bayer AG performed very badly with a performance of -51.27%. Biggybaer has a follow-up prediction for Bayer AG where he still thinks Bayer AG is a Buy. A total of €2.55 was paid as dividends for this prediction. This prediction was marked as speculative and is excluded from Biggybaer's performance statistics.Bayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | 1.164% | 1.164% | 96.441% | -33.317% |
| iShares Core DAX® | 0,44 % | 3,03 % | 12,68 % | 49,79 % |
| iShares Nasdaq 100 | 3,82 % | 4,07 % | 33,15 % | 88,25 % |
| iShares Nikkei 225® | 1,15 % | 6,90 % | 45,49 % | 61,92 % |
| iShares S&P 500 | 2,37 % | 2,68 % | 25,69 % | 63,54 % |
Comments by Biggybaer for this prediction
In the thread Bayer AG diskutieren
Buy mit Kursziel 65,0
In the thread Trading Bayer AG
Die von Biggybaer gewählte maximale Laufzeit wurde überschritten